DPP-IV inhibitors (East China University of Science & Technology/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDPP-IV inhibitors (East China University of Science & Technology/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesEast China University Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEast China University Of Science And TechnologyShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A